These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16998251)

  • 1. Pancreatic ductal carcinoma: from the bench to the bedside.
    Pezzilli R
    JOP; 2006 Sep; 7(5):508-10. PubMed ID: 16998251
    [No Abstract]   [Full Text] [Related]  

  • 2. Exocrine-endocrine pancreatic cancer and alpha-fetoprotein.
    Brandi G; Nobili E; Capizzi E; Corti B; Di Cicilia R; Di Marco M; Biasco G
    Pancreas; 2008 Aug; 37(2):223-5. PubMed ID: 18665089
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraductal papillary mucinous neoplasms of the pancreas: should we side step the side branches?
    Bishop MD; Wallace MB
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):724-5. PubMed ID: 18602034
    [No Abstract]   [Full Text] [Related]  

  • 4. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
    J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated histone deacetylase 1 expression in pancreatic ductal adenocarcinoma and specific siRNA inhibits the growth of cancer cells.
    Gao DJ; Xu M; Zhang YQ; Du YQ; Gao J; Gong YF; Man XH; Wu HY; Jin J; Xu GM; Li ZS
    Pancreas; 2010 Oct; 39(7):994-1001. PubMed ID: 20467347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraductal papillary mucinous neoplasms (IPMNs): is it time to (sometimes) spare the knife?
    Bassi C; Crippa S; Salvia R
    Gut; 2008 Mar; 57(3):287-9. PubMed ID: 18268051
    [No Abstract]   [Full Text] [Related]  

  • 7. Islets and pancreatic ductal adenocarcinoma - An opportunity for translational research from the 'Bench to the Bedside'.
    Barreto SG; Michael MZ; Keating DJ
    Pancreatology; 2020 Apr; 20(3):385-390. PubMed ID: 32057682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology of adenocarcinoma of the pancreatic duct, current state and future therapeutic avenues.
    Abbas S
    Surg Oncol; 2013 Jun; 22(2):69-76. PubMed ID: 23415924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia.
    Agarwal AK
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):221. PubMed ID: 18533322
    [No Abstract]   [Full Text] [Related]  

  • 10. Location, location, location: precursors and prognoses for pancreatic cancer.
    Hingorani SR
    Gastroenterology; 2007 Jul; 133(1):345-50. PubMed ID: 17631154
    [No Abstract]   [Full Text] [Related]  

  • 11. Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype?
    Chandana S; Mahadevan D
    Expert Rev Mol Med; 2009 Nov; 11():e34. PubMed ID: 19919723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches.
    Orth M; Metzger P; Gerum S; Mayerle J; Schneider G; Belka C; Schnurr M; Lauber K
    Radiat Oncol; 2019 Aug; 14(1):141. PubMed ID: 31395068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic cancer development and progression: remodeling the model.
    Real FX; Cibrián-Uhalte E; Martinelli P
    Gastroenterology; 2008 Sep; 135(3):724-8. PubMed ID: 18692502
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia.
    Bhanot UK
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):106-7. PubMed ID: 18234650
    [No Abstract]   [Full Text] [Related]  

  • 15. Revising you the staging for pancreatic cancer in 2012.
    Saif MW
    JOP; 2012 Mar; 13(2):128-30. PubMed ID: 22406582
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
    Hiraoka N; Onozato K; Kosuge T; Hirohashi S
    Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of Death and Conditional Survival Estimates of Medium- and Long-term Survivors of Pancreatic Adenocarcinoma.
    Swords DS; Mulvihill SJ; Firpo MA; Scaife CL
    JAMA Oncol; 2018 Aug; 4(8):1129-1130. PubMed ID: 30003235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral-mediated gene transfer of Gadd45a results in suppression by inducing apoptosis and cell cycle arrest in pancreatic cancer cell.
    Li Y; Qian H; Li X; Wang H; Yu J; Liu Y; Zhang X; Liang X; Fu M; Zhan Q; Lin C
    J Gene Med; 2009 Jan; 11(1):3-13. PubMed ID: 19003803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of ductal adenocarcinoma during follow-up of branch-duct IPMNs.
    Crippa S; Salvia R; Bassi C
    Gut; 2009 Jun; 58(6):889-90. PubMed ID: 19433610
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoadjuvant therapy for pancreatic cancer.
    Kleeff J; Friess H; Büchler MW
    Br J Surg; 2007 Mar; 94(3):261-2. PubMed ID: 17315287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.